FDAFDA · Food and drugs·Recall number D-0305-2020
Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10
Published November 13, 2019 · Recall initiated: November 1, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign substance: identified as a dead ant.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CEFDINIR
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed to major distributors/wholesalers throughout the United States.
- UPC
- 0368180723042
- Lot
- Lot #: F802345, F802346, F802347, Exp 11/20
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.